- Home
- SF vs BAX Comparison
SF vs BAX Comparison
Compare SF & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SF | BAX |
|---|---|---|
| Founded | 1890 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SF | BAX |
|---|---|---|
| Price | $118.71 | $18.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 10 |
| Target Price | ★ $133.75 | $25.00 |
| AVG Volume (30 Days) | 1.1M | ★ 8.7M |
| Earning Date | 01-28-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.65% | 0.18% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.87 | N/A |
| Revenue | $5,529,730,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $16.23 | $5.22 |
| Revenue Next Year | $7.61 | $1.98 |
| P/E Ratio | $21.13 | ★ N/A |
| Revenue Growth | ★ 11.83 | 3.90 |
| 52 Week Low | $73.27 | $17.40 |
| 52 Week High | $134.74 | $37.74 |
Technical Indicators
Market Signals| Indicator | SF | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 34.63 | 38.76 |
| Support Level | $121.08 | $21.10 |
| Resistance Level | $131.72 | $22.41 |
| Average True Range (ATR) | 4.49 | 0.68 |
| MACD | -0.67 | 0.00 |
| Stochastic Oscillator | 18.96 | 6.26 |
Price Performance
Historical ComparisonAbout SF Stifel Financial Corporation
Stifel Financial is a diversified financial-services provider that generates revenue from wealth management, investment banking, and lending. The firm was founded in 1890 as a St. Louis-based full-service brokerage but has been transformed under CEO Ronald Kruszewski through a slew of acquisitions into a globally competitive wealth manager, investment bank, and retail and institutional brokerage. The firm generated $5.5 billion in revenue in 2025, with roughly two-thirds derived from wealth management and one-third derived from investment banking and trading.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.